The C C motif chemokine ligand 11 contributes to alcoholic liver disease
Life Sciences · 2025-02 · 363 · 123409
DOI: 10.1016/j.lfs.2025.123409 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Sciences, 2025-02. Verfasst von Jichen Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural Medicines, Department of Pharmacology, China Pharmaceutical University, Nanjing, China. Hauptthemen laut MEDLINE: Liver Diseases, Alcoholic, Chemokine CCL11. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Health Commission of Chengdu Municipality.
Abstract (Originalsprache)
AIMS: Alcoholic liver disease (ALD) is characterized by aberrant lipid metabolism and chronic inflammation that eventually give rise to cirrhosis and hepatocellular carcinoma. In the present study we investigated the contribution of CC motif chemokine ligand 11 (CCL11) to ALD pathogenesis. METHODS AND MATERIALS: ALD was induced in mice by binge ethanol gavage or chronic ethanol feeding. KEY FINDINGS: Bioinformatic analysis of sequencing data indicated that CCL11 expression was up-regulated in hepatocytes from mice subjected to ethanol feeding compared to those from the control mice. Exposure to ethanol led to CCL11 up-regulation in primary murine hepatocytes in vitro. Consistently, Oil Red O (ORO) staining detected elevated lipid accumulation whereas quantitative PCR (qPCR) detected augmented expression of pro-inflammatory mediators in primary murine hepatocytes treated with recombinant CCL11. On the contrary, CCL11 knockout mice (KO) developed a less severe form of ALD compared to wild type littermates when subjected to either binge or chronic ethanol feeding. Finally, CCL11 antagonism by administration with an inhibitor to CCL11 receptor CCR3 (CCR3i) attenuated ALD in mice. SIGNIFICANCE: Our data support a role for CCL11 in ALD pathogenesis and provide proof-of-concept that targeting CCL11 can be considered as a therapeutic approach for ALD intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Natural Medicines, Department of Pharmacology, China Pharmaceutical University, Nanjing, China.
- Pediatric Intensive Care Unit, Children's Hospital of Nanjing Medical University, Nanjing, China.
- Institute of Biomedical Research, College of Agriculture and Biology, Liaocheng University, Liaocheng, China.
- Department of Hepatobiliary Surgery, Jintan Affiliated Hospital of Jiangsu University, Changzhou, China.
- Institute of Biomedical Research, College of Agriculture and Biology, Liaocheng University, Liaocheng, China. Electronic address: miaoxiulian@lcu.edu.cn.
- Institute of Biomedical Research, College of Agriculture and Biology, Liaocheng University, Liaocheng, China. Electronic address: guoyan@lcu.edu.cn.
Förderung
- Health Commission of Chengdu Municipality
Zitieren
APA
Li, J., Wang, B., Wang, S., Wang, J., Zhou, A., Gong, S., Wang, Y., Miao, X., Guo, Y., Wang, H., & Ge, H. (2025). The C C motif chemokine ligand 11 contributes to alcoholic liver disease. Life Sciences, 363, 123409. https://doi.org/10.1016/j.lfs.2025.123409
Vancouver
Li J, Wang B, Wang S, Wang J, Zhou A, Gong S, et al. The C C motif chemokine ligand 11 contributes to alcoholic liver disease. Life Sciences. 2025;363:123409. doi:10.1016/j.lfs.2025.123409
BibTeX
@article{Li2025,
author = {Li, Jichen and Wang, Ben and Wang, Shunjie and Wang, Jieguo and Zhou, Anqi and Gong, Shanwen and Wang, Yu and Miao, Xiulian and Guo, Yan and Wang, Hao and Ge, Hailong},
title = {The C C motif chemokine ligand 11 contributes to alcoholic liver disease},
journal = {Life Sciences},
year = {2025},
volume = {363},
pages = {123409},
doi = {10.1016/j.lfs.2025.123409}
}
EUVIMED